SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-015548
Filing Date
2024-06-05
Accepted
2024-06-05 16:10:36
Documents
2
Period of Report
2024-06-01

Document Format Files

Seq Description Document Type Size
1 form3-06052024_080632.html 3  
1 form3-06052024_080632.xml 3 2364
2 ex24-06052024_080632.htm EX-24 6745
  Complete submission text file 0001415889-24-015548.txt   10478
Mailing Address 925 PAGE MILL ROAD PALO ALTO CA 94304
Business Address
BIENAIME JEAN JACQUES (Reporting) CIK: 0001221590 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39264 | Film No.: 241022104

Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Issuer) CIK: 0001664710 (see all company filings)

IRS No.: 811173868 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)